DRD2 and schizophrenia: GQS values confirmed the association of schizophrenia with variants in loci containing the cholinergic muscarinic receptor 4 (CHRM4) and dopamine D2 receptor (DRD2) (The Schizophrenia Working Group of the Psychiatric Genomics Consortium et al., 2020).